Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis

Endocrinology

Volumn 145, Issue 12, 2004, Pages 5431-5438

  Patel, Sachin ^a   Roelke, Craig T ^a   Rademacher, David J ^a   Cullinan, William E ^b   Hillard, Cecilia J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b MARQUETTE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 ARACHIDONOYLGLYCEROL; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; CORTICOSTERONE; CYCLOHEXYLCARBAMIC ACID 3 CARBAMOYLBIPHENYL 3 YL ESTER; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; ENZYME INHIBITOR; FATTY ACID AMIDASE; FATTY ACID AMIDASE INHIBITOR; N (4 HYDROXYPHENYL)ARACHIDONAMIDE; PROTEIN FOS; RIMONABANT; UNCLASSIFIED DRUG;

ADAPTATION; ANIMAL TISSUE; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MOUSE; NEUROENDOCRINE SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STRESS; SURVIVAL; THALAMUS MIDLINE NUCLEUS;

ACUTE DISEASE; ANIMALS; CORTICOSTERONE; ENDOCANNABINOIDS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MICE; MICE, INBRED ICR; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PITUITARY-ADRENAL SYSTEM; PROTO-ONCOGENE PROTEINS C-FOS; RECEPTOR, CANNABINOID, CB1; RESTRAINT, PHYSICAL; SIGNAL TRANSDUCTION; STRESS;

EID: 9444277292     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2004-0638     Document Type: Article

References (30)

1. Herman JP, Figueiredo H, Mueller NK, Ulrich-Lai Y, Ostrander MM, Choi DC, Cullinan WE 2003 Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness. Front Neuroendocrinol 24:151-180
2. Herman JP, Tasker JG, Ziegler DR, Cullinan WE 2002 Local circuit regulation of paraventricular nucleus stress integration: glutamate-GABA connections. Pharmacol Biochem Behav 71:457-468
3. Wolkowitz OM, Epel ES, Reus VI 2001 Stress hormone-related psychopathology: pathophysiological and treatment implications. World J Biol Psychiatry 2:115-143
4. Raber J 1998 Detrimental effects of chronic hypothalamic-pituitary- adrenal axis activation. From obesity to memory deficits. Mol Neurobiol 18:1-22
5. Korte SM 2001 Corticosteroids in relation to fear, anxiety and psychopathology. Neurosci Biobehav Rev 25:117-142
6. Piomelli D 2003 The molecular logic of endocannabinoid signalling. Nat Rev Neurosci 4:873-884
7. Kathuria S, Gaetani S, Fegley D, Valino F, Duranti A, Tontini A, Mor M, Tarzia G, La Rana G, Calignano A, Giustino A, Tattoli M, Palmery M, Cuomo V, Piomelli D 2003 Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med 9:76-81
8. 9-tetrahydrocannabinol. Psychopharmacology 163:111-117
9. 9-tetrahydrocannabinol and nicotine. Br J Pharmacol 135:564-578
10. Navarro M, Hernandez E, Munoz RM, del Arco I, Villanua MA, Carrera MR, Rodriguez de Fonseca F 1997 Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat. Neuroreport 8:491-496
11. Arevalo C, de Miguel R, Hernandez-Tristan R 2001 Cannabinoid effects on anxiety-related behaviours and hypothalamic neurotransmitters. Pharmacol Biochem Behav 70:123-131
12. Rodgers RJ, Haller J, Halasz J, Mikics E 2003 'One-trial sensitization' to the anxiolytic-like effects of cannabinoid receptor antagonist SR141716A in the mouse elevated plus-maze. Eur J Neurosci 17:1279-1286
13. Haller J, Varga B, Ledent C, Barna I, Freund TF 2004 Context-dependent effects of CB1 cannabinoid gene disruption on anxiety-like and social behaviour in mice. Eur J Neurosci 19:1906-1912
14. 9-tetrahydrocannabinol in rats. Brain Res 839:173-179
15. Di S, Malcher-Lopes R, Halmos KC, Tasker JG 2003 Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism. J Neurosci 23:4850-4857
16. Patel S, Hillard CJ 2003 Cannabinoid-induced Fos expression within A10 dopaminergic neurons. Brain Res 963:15-25
17. Tsou K, Nogueron MI, Muthian S, Sanudo-Pena MC, Hillard CJ, Deutsch DG, Walker JM 1998 Fatty acid amide hydrolase is located preferentially in large neurons in the rat central nervous system as revealed by immunohistochemistry. Neurosci Lett 254:137-140
18. Patel S, Rademacher DJ, Hillard CJ 2003 Differential regulation of the endocannabinoids anandamide and 2-arachidonylglycerol within the limbic forebrain by dopamine receptor activity. J Pharmacol Exp Ther 306:880-888
19. Brake WG, Flores G, Francis D, Meaney MJ, Srivastava LK, Gratton A 2000 Enhanced nucleus accumbens dopamine and plasma corticosterone stress responses in adult rats with neonatal excitotoxic lesions to the medial prefrontal cortex. Neuroscience 96:687-695
20. 9-tetrahydrocannabinol on serum thyrotropin levels in the rat. Pharmacol Biochem Behav 20:547-550
21. 8-tetrahydrocannabinol-dimethylheptyl (HU-210), a potent synthetic cannabinoid in rats. Eur J Pharmacol 344:77-86
22. 1- tetrahydrocannabinol, in intact and in hypothalamic deafferentated male rats. Exp Brain Res 46:85-88
23. Pagotto U, Marskano G, Fezza F, Theodoropoulou M, Grubler Y, Stalla J, Arzberger T, Milone A, Losa M, Di Marzo V, Lutz B, Stalla GK 2001 Normal human pituitary gland and pituitary adenomas express cannabinoid receptor type 1 and synthesize endogenous cannabinoids: first evidence for a direct role of cannabinoids on hormone modulation at the human pituitary level. J Clin Endocrinol Metab 86:2687-2696
24. Katona I, Rancz EA, Acsady L, Ledent C, Mackie K, Hajos N, Freund TF 2001 Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. J Neurosci 21:9506-9518
25. Marskano G, Wotjak CT, Azad SC, Bisogno T, Rammes G, Cascio MG, Hermann H, Tang J, Hofmann C, Zieglgansbergei W, Di Marzo V, Lutz B 2002 The endogenous cannabinoid system controls extinction of aversive memories. Nature 418:530-534
26. Beltramo M, Stella N, Calignano A, Lin SY, Makriyannis A, Piomelli D 1997 Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science 277:1094-1097
27. Beltramo M, Piomelli D 2000 Carrier-mediated transport and enzymatic hydrolysis of the endogenous cannabinoid 2-arachidonylglycerol. Neuroreport 11:1231-1235
28. Jarrahian A, Manna S, Edgemond WS, Campbell WB, Hillard CJ 2000 Structure activity relationships among N-arachidonylethanolamine (anandamide) head group analogues for the anandamide transporter. J Neurochem 74:2597-2606
29. Thomas H 1996 A community survey of adverse effects of cannabis use. Drug Alcohol Depend 42:201-207
30. Szuster RR, Pontius EB, Campos PE 1988 Marijuana sensitivity and panic anxiety. J Clin Psychiatry 49:427-429